100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
ASCP PHLEBOTOMY CERTIFICATION EXAM QUESTIONS AND ANSWERS WITH SOLUTIONS 2024 R280,01   Add to cart

Exam (elaborations)

ASCP PHLEBOTOMY CERTIFICATION EXAM QUESTIONS AND ANSWERS WITH SOLUTIONS 2024

 9 views  0 purchase
  • Course
  • ASCP CERTIFICATION
  • Institution
  • ASCP CERTIFICATION

ASCP PHLEBOTOMY CERTIFICATION EXAM QUESTIONS AND ANSWERS WITH SOLUTIONS 2024

Preview 3 out of 16  pages

  • August 11, 2024
  • 16
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • ASCP CERTIFICATION
  • ASCP CERTIFICATION
avatar-seller
ASCP PHLEBOTOMY CERTIFICATION
EXAM QUESTIONS AND ANSWERS
WITH SOLUTIONS 2024
DISINFECTANTS ARE: - ANSWER CHEMICALS THAT ARE USED TO REMOVE OR KILL PATHOGENIC
MICROORGANISMS



BABIES WHOSE MOTHERS HAVE WHICH OF THE FOLLOWING PROBLEMS MUST BE ISOLATED FROM
OTHER INFANTS? - ANSWER GENITAL HERPES



WHICH OF THE FOLLOWING IS A VECTOR IN TRANSMITTING INFECTIOUS DISEASES? - ANSWER MITES



WHICH OF THE FOLLOWING IS A COMMONLY IDENTIFIED PATHOGENIC MICROORGANISM THAT CAUSES
HEALTH CARE ASSOCIATED SKIN INFECTIONS? - ANSWER CANDIDA ALBICANS



WHICH OF THE FOLLOWING ORGANIZATIONS OVERSEES THE INVESTIGATION AND CONTROL OF VARIOUS
DISEASES ESPECIALLY THOSE THAT ARE COMMUNICABLE? - ANSWER CDC



WHICH OF THE FOLLOWING IS A COMMONLY IDENTIFIED PATHOGENIC AGENT THAT AFFECTS THE SKIN?
- ANSWER HERPES VIRUS



REVERSE ISOLATION IS COMMONLY USED FOR PATIENTS WHO HAVE: - ANSWER IMMUNODEFICIENCY
DISORDERS



WHICH OF THE FOLLOWING IS A COMMONLY IDENTIFIED CAUSATIVE AGENT OF NOSOCOMIAL
INFECTIONS IN THE NURSERY UNIT? - ANSWER ESCHERICHIA COLI



WHICH OF THE FOLLOWING CHEMICAL COMPOUNDS IS AN ANTISEPTIC FOR SKIN? - ANSWER
HEXYLRESORCINOL



A PHLEBOTOMIST HAD TO AVOID CONTACT WITH PATIENTS FOR 24 HOURS AFTER BEING STARTED ON
AN APPROPRIATE ANTIBIOTIC AND APPEARING SYMPTOM FREE. WHAT TYPE OF INFECTION COULD HE

,OR SHE HAVE ACQUIRED FOR THE ABOVE WORK LIMITATIONS TO APPLY? - ANSWER STREP THROAT
(GROUP A)



THE HICPAC TRANSMISSION BASED PRECAUTIONS INCLUDE: - ANSWER AIRBORNE, DROPLET, AND
CONTACT



ABOUT HOW MANY PATIENTS ACQUIRE A NOSOCOMIAL INFECTION ANNUALLY? - ANSWER 1.75 TO 3
MILLION



A HEALTH CARE ACQUIRED INFECTION OCCURS WHEN: - ANSWER THE CHAIN OF INFECTION IS
COMPLETE



IN HEALTH CARE FACILITIES, WHICH OF THE FOLLOWING IS A TYPICAL FOMITE? - ANSWER PHLEBOTOMY
TRAY



WHICH OF THE FOLLOWING IS A FACTOR THAT INCREASES A HOST'S SUSCEPTIBILITY IN THE CHAIN OF
INFECTION? - ANSWER DRUG USE



ANTISEPTICS FOR SKIN INCLUDE: - ANSWER IODINE



IF AN ELECTRICAL ACCIDENT OCCURS INVOLVING ELECTRICAL SHOCK TO AN EMPLOYEE OR A PATIENT,
THE FIRST THING THAT THE HEALTH CARE PROVIDER SHOULD DO IS: - ANSWER SHUT OFF THE
ELECTRICAL POWER



WHAT THE MAJOR PRINCIPLES OF SELF PROTECTION FROM RADIATION EXPOSURE? - ANSWER TIME,
DISTANCE, AND SHIELDING



THE FIRST STEP IN GIVING MOUTH TO MOUTH RESUSCITATION IS TO: - ANSWER DETERMINE WHETHER
THE VICTIM IS CONSCIOUS BY GENTLY TAPPING THE SHOULDERS OF THE VICTIM AND SPEAKING LOUDLY,
"ARE YOU OKAY?"



IF A FIRE EXTINGUISHER HAS TO BE USED IN A HEALTH CARE ENVIRONMENT, THE FIRST STEP TO
PERFORM IS: - ANSWER PULL THE PIN OFF OF THE EXTINGUISHER

, IF A PHLEBOTOMIST IS COLLECTING BLOOD SPECIMENS FROM A PATIENT IN THE NUCLEAR MEDICINE
DEPARTMENT HE OR SHE NEEDS TO BE: - ANSWER WEARING A DOSIMETER BADGE



WHICH ORGANIZATION DEVELOPED A LABELING SYSTEM FOR HAZARDOUS CHEMICALS THAT IS
FREQUENTLY USED IN HEALTH CARE FACILITIES? - ANSWER NFPA



THE FIRST STEP IN CONTROLLING SEVERE BLEEDING IS TO: - ANSWER APPLY PRESSURE DIRECTLY OVER
THE WOUND OR VENIPUNCTURE SITE



CHEMICALS THAT ARE DEFINED AS "EXPLOSIVE FLAMMABLES" MUST BE STORED: - ANSWER IN AN
EXPLOSION PROOF OR FIREPROOF ROOM OR CABINET



WHICH OF THE FOLLOWING SHOULD NOT BE DONE FOR A SHOCK VICTIM WHO SEEMS TO BE NOT FULLY
CONSCIOUS? - ANSWER GIVE FLUIDS TO KEEP THE VICTIM FROM BECOMING DEHYDRATED



CLASS C FIRES ARE: - ANSWER ELECTRICAL FIRES



MSDSs MUST BE SUPPLIED TO EMPLOYEES ACCORDING TO THE: - ANSWER HAZARD COMMUNICATION
STANDARD (29 CFR 1910.1200)



HOW MANY LOBES DO NORMAL HUMAN LUNGS HAVE? - ANSWER 5



AFTER OXYGEN CROSSES THE RESPIRATORY MEMBRANES (IN THE LUNG) INTO THE BLOOD, ABOUT 97%
OF IT COMBINES WITH? - ANSWER HEMOGLOBIN



THE TERM VENTRAL REFERS TO WHICH PART OF THE BODY? - ANSWER FRONT



IF A NORMAL PERSON BREATHES IN, THE OXYGEN TRAVELS THROUGH AIR PASSAGES TO THE LUNGS.
WHICH OF THE FOLLOWING TAKES PLACE? - ANSWER OXYGEN (O2) IS EXCHANGED FOR CARBON
DIOXIDE (CO2)

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying this summary from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Performance. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy this summary for R280,01. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

73918 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy summaries for 14 years now

Start selling
R280,01
  • (0)
  Buy now